Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Homepage
Tags search
Pharmaceuricals

CTech 24/7

Pharmaceuricals

3 stories about Pharmaceuricals

Closure of another criminal case will help Teva's new CEO to focus on return to growth
22.08.23|Sophie ShulmanThe pharmaceutical company has reached a compromise after being suspected of price-fixing with other generic drug manufacturers in the US. In the first four years, it will pay $22.5 million and in 2028 - $135 million. In addition, the company will donate two drugs worth $50 million to humanitarian organizations
Schultz kept Teva away from the abyss, but couldn't find a runway to growth
22.11.22|Sophie ShulmanKare Schultz, who served as CEO of the pharmaceutical company for the past five years, has left the company a year early after amassing a salary of more than $100 million. His replacement, Richard Francis, is taking over with less debt and less legal issues, but with the big challenge of creating new growth engines
United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal
30.04.18|Amarelle WenkertIn 2017, Israeli-founded SteadyMed won a patent war against United Therapeutics

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

Pharmaceuricals

Closure of another criminal case will help Teva's new CEO to focus on return to growth

Schultz kept Teva away from the abyss, but couldn't find a runway to growth

United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal